Maturitas · 2012
Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chedraui Peter, San Miguel Glenda, Villacreses Diego, Dominguez Andrea, Jaramillo Winston, Escobar Gustavo S, Pérez-López Faustino R, Genazzani Andrea R, Simoncini Tommaso, Research Group for the Omega Women's Health Project
Аннотация
BACKGROUND: Sleep disturbances are common during female mid-life. Nevertheless, there is limited available information linking sleep characteristics to the menopause and the metabolic syndrome (METS).
OBJECTIVE: To assess insomnia prevalence and related risk factors in postmenopausal women screened for the METS.
METHODS: In this cross sectional study 204 natural postmenopausal women participating in a METS screening program filled out the Athens insomnia scale (AIS), the hospital anxiety and depression scale (HADS) and a general socio-demographic questionnaire. Criteria of the Adult Treatment Panel III (ATP-III) were used to define the METS.
RESULTS: Median age of the whole sample was 56 years. A 50.5% of women had the METS, 57.4% hot flushes, 58.3% were abdominally obese, 51.5% hypertension, 25.0% hyperglycemia, 15.7% depressed mood and 29.9% anxiety. A 33.8% presented insomnia according to the AIS (scores 6 or more). The AIS displayed a high internal consistency as computed Cronbach's alpha was determined to be 0.86. Multiple linear regression analysis determined that male premature ejaculation, female psychotropic drug use, hot flush intensity, mood morbidity (higher total HADS scores) and higher parity positively and significantly correlated to higher AIS scores (more insomnia).
CONCLUSION: In this postmenopausal sample insomnia was not related to the METS or its components yet to other psycho-somatic female and partner issues.
OBJECTIVE: To assess insomnia prevalence and related risk factors in postmenopausal women screened for the METS.
METHODS: In this cross sectional study 204 natural postmenopausal women participating in a METS screening program filled out the Athens insomnia scale (AIS), the hospital anxiety and depression scale (HADS) and a general socio-demographic questionnaire. Criteria of the Adult Treatment Panel III (ATP-III) were used to define the METS.
RESULTS: Median age of the whole sample was 56 years. A 50.5% of women had the METS, 57.4% hot flushes, 58.3% were abdominally obese, 51.5% hypertension, 25.0% hyperglycemia, 15.7% depressed mood and 29.9% anxiety. A 33.8% presented insomnia according to the AIS (scores 6 or more). The AIS displayed a high internal consistency as computed Cronbach's alpha was determined to be 0.86. Multiple linear regression analysis determined that male premature ejaculation, female psychotropic drug use, hot flush intensity, mood morbidity (higher total HADS scores) and higher parity positively and significantly correlated to higher AIS scores (more insomnia).
CONCLUSION: In this postmenopausal sample insomnia was not related to the METS or its components yet to other psycho-somatic female and partner issues.
Предметные рубрики MeSH
AdultAgedAnxietyCross-Sectional StudiesDepressionFemaleHot FlashesHumansHyperglycemiaHypertensionLinear ModelsMaleMetabolic SyndromeMiddle AgedObesity, AbdominalParityPostmenopausePrevalencePsychotropic DrugsRisk FactorsSexual BehaviorSleep Initiation and Maintenance DisordersStatistics, Nonparametric